These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Thailand's Prime-Boost HIV Vaccine Phase III. Trinvuthipong C Science; 2004 Feb; 303(5660):954-5. PubMed ID: 14963308 [No Abstract] [Full Text] [Related]
6. HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand. Rerks-Ngarm S; Brown AE; Khamboonruang C; Thongcharoen P; Kunasol P AIDS; 2006 Jul; 20(11):1471-9. PubMed ID: 16847401 [No Abstract] [Full Text] [Related]
7. Phase II prime-boost trial begins in the U.S. McEnery R IAVI Rep; 2009; 13(4):18. PubMed ID: 20225577 [No Abstract] [Full Text] [Related]
8. Human trials of experimental HIV vaccines. Burke DS AIDS; 1995; 9 Suppl A():S171-80. PubMed ID: 8819583 [No Abstract] [Full Text] [Related]
9. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model. Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672 [TBL] [Abstract][Full Text] [Related]
10. Two preventive AIDS vaccine trials begin. IAVI Rep; 2006; 10(3):19. PubMed ID: 20213981 [No Abstract] [Full Text] [Related]
11. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines. Robinson HL; Weinhold KJ J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331 [No Abstract] [Full Text] [Related]
12. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection. Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358 [TBL] [Abstract][Full Text] [Related]
13. Immunization. Update: search for an AIDS vaccine. Bende S; Johnston MI AIDS Read; 2000 Sep; 10(9):526-32, 534-8. PubMed ID: 11019448 [TBL] [Abstract][Full Text] [Related]
14. Update on HIV vaccines. Meldorf M; Corey L STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929 [TBL] [Abstract][Full Text] [Related]
15. [Perspectives for the development of preventive vaccines against HIV/AIDS]. Esparza J Medicina (B Aires); 1998; 58 Suppl 1():57-63. PubMed ID: 9674249 [No Abstract] [Full Text] [Related]
16. Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be? Smith RJ; Schwartz EJ Math Biosci; 2008 Apr; 212(2):180-7. PubMed ID: 18359048 [TBL] [Abstract][Full Text] [Related]
18. Cold shower for AIDS vaccines. Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013 [No Abstract] [Full Text] [Related]
19. A review of vaccine research and development: the human immunodeficiency virus (HIV). Girard MP; Osmanov SK; Kieny MP Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298 [TBL] [Abstract][Full Text] [Related]
20. HIV vaccine trials in India. Berkley S Nat Biotechnol; 2008 May; 26(5):495; author reply 496. PubMed ID: 18464771 [No Abstract] [Full Text] [Related] [Next] [New Search]